Cambridge, UK, 30th March 2017 / Sciad Newswire / Domainex Ltd, a privately-owned drug discovery services company, is ple
Biotechnology
Thu, 16/03/2017 - 07:30
Edinburgh, UK, 16th March 2017 / Sciad Newswire / Synpromics Ltd, the leading synthetic promoter and gene control company
Wed, 15/03/2017 - 10:10
Moncton, Canada, 15th March 2017 / Sciad Newswire / The Atlantic Cancer Research Institute (ACRI) is pleased to announc
Wed, 01/03/2017 - 07:30
Cambridge, UK, 1st March 2017 / Sciad Newswire / Cypralis, a life sciences company focussed on the discovery of therapeutic
Tue, 21/02/2017 - 07:30
Cleveland, UK, 21st February 2017 / Sciad Newswire / Cambridge Research Biochemicals® (CRB), a longstanding
Tue, 14/02/2017 - 07:30
London, UK, 14th February 2017 / Sciad Newswire / Biosys UK Limited (“Biosys” or the “Company
Fri, 10/02/2017 - 09:30
Ongar, UK, 10th February 2017 / Sciad Newswire / Selcia, with colleagues from Cypralis and Gilead Sciences Inc., have publish
Thu, 09/02/2017 - 07:30
Epsom, UK, 9th February 2017 / Sciad Newswire / Now is the time for the consumer electronics industry to adopt plastic electronics as new devices are set to revol
Thu, 09/02/2017 - 07:30
Epsom, UK, 9th February 2017 / Sciad Newswire / Now is the time for healthcare innovators to adopt plastic electronics and revolutionise healthcare monitoring and
Mon, 06/02/2017 - 07:30
Medherant Ltd., a University of Warwick spin-out developing a novel transdermal drug delivery patch technology, is pleased to announce the appointment of Dr Ken Cunningham as Chair. Dr Cunningham joins Medherant as the company prepares to move into clinical studies with its leading TEPI Patch® technology.